By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ExonHit Therapeutics Inc. 

Avenel Business Park
217 Perry Parkway
Gaithersburg  Maryland  20877  U.S.A.
Phone: 240-683-7070 Fax: 240-683-7060



Company News
ExonHit Therapeutics Inc. Receives € 1.93 Million from OSEO Within the Personalized Medicine TEDAC Project in Cancer 6/5/2012 10:32:56 AM
ExonHit Therapeutics Inc. is Beneficiary of a Grant from the European Union Within the Responsify Consortium 3/5/2012 10:09:13 AM
ExonHit Therapeutics Inc.: AclarusDx®: Launch of Observational Study in France 12/12/2011 10:49:57 AM
ExonHit Therapeutics Inc. Extends Strategic Collaboration with Allergan Inc. (AGN) 11/2/2011 7:39:45 AM
Approval of US Pilot Clinical Trial to Evaluate AclarusDx(™), the ExonHit Therapeutics Inc. Investigational Test for Alzheimer’s Disease Diagnosis 10/26/2011 11:14:59 AM
ExonHit Therapeutics Inc. and Beijing Genomics Institute (BGI) Announce Successful Completion of a Promising Next-Generation Sequencing Project 7/25/2011 11:00:10 AM
ExonHit Therapeutics Inc. Announces Successful Completion of the Second Phase of EHT Dx14 Clinical Validation 7/19/2011 11:12:45 AM
ExonHit Therapeutics Inc. Reports Key Progress in the Introduction of AclarusDx(TM) in the French IVD Market 6/29/2011 10:53:00 AM
ExonHit Therapeutics Inc.'s Extraordinary Shareholders’ Meeting 5/18/2011 10:33:53 AM
ExonHit Therapeutics Inc. Announces Publication of EHT 0202 Phase IIa Results in Current Alzheimer Research 4/5/2011 10:41:15 AM